People: BTG PLC (BTG.L)
18 Apr 2019
Mr. Duncan Kennedy is Chief Financial Officer, Executive Director of the Company. Duncan currently leads BTG's Interventional Oncology business, a role he has held since May 2015. He joined BTG in December 2005 as Group Financial Controller and became a member of the Leadership Team in April 2012 when he was appointed Group Director of Finance, with responsibility for managing the global finance function and supporting the CFO. Prior to joining BTG, Duncan spent six years in the group finance function of Wembley plc. Duncan qualified as a Chartered Accountant at Arthur Andersen and holds a BSc in Mathematics from Durham University.
|Total Annual Compensation, GBP||191,000|
|Restricted Stock Award, GBP||--|
|Long-Term Incentive Plans, GBP||105,000|
|All Other, GBP||20,000|
|Fiscal Year Total, GBP||316,000|